Stories for Change: Early Detection Can Save Lives

NCT05956353 | Completed

• 1 other identifier: 23-001860
• Study Type: interventional
• Target: 51
• Locations: 1 country
• Sites: 3

Brief Summary

The purpose of this study is to evaluate the Stories for Change (S4C) Cancer Prevention digital storytelling intervention for acceptability and socio-behavioral constructs to increase cancer screening among Hispanic or Latino individuals.

Conditions

Prevention

Outcome Measures

Primary Outcomes (1)

• Number of participants screened and recruited

  Our primary measure is the number of participants screened and recruited. We need this information to calculate the number needed to screen in order to recruit one participant from each site in our future randomized controlled trial.

  1 year

Secondary Outcomes (1)

• Constructs associated with effective implementation research

  1 year

Study Arms (1)

Stories for Change: Prevention (S4C) intervention

EXPERIMENTAL

Participants who are due or overdue for cancer screening will receive the digital storytelling intervention and complete a cross-sectional survey to assess intervention acceptability, socio-behavioral constructs, and theory-based constructs.

Behavioral: Digital Storytelling Intervention

Interventions

Digital Storytelling Intervention BEHAVIORAL

Culturally tailored narrative-based videos created by individuals to promote colorectal, breast and cervical cancer screening among eligible participants in a primary care practice.

Stories for Change: Prevention (S4C) intervention

Eligibility Criteria

• Age: 21 Years - 75 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Self-identify as Hispanic, Latino/a/x/e, or Chicano/a/x;
• For breast cancer screening: age 40-74 years; for cervical cancer screening: age 21-65 years; for colorectal cancer screening: age 45-75 year
• Receive primary care at either Hennepin Healthcare (HH) or Mountain Park Health Center (MPHC), or Mayo Clinic.
• At least one office visit within the previous 12 months to the primary care site.
• Eligibility for breast, cervical, or colorectal cancer screening documented in the electronic medical record (EMR).
• Intention to continue to receive medical care at HH, MPHC or Mayo Clinic for the next three months.
• If a potential participant is eligible for more than one screening, they will be given the option of participating in multiple versions of the intervention.

You may not qualify if:

• Individuals with previous breast, cervical, or colorectal cancer diagnoses.
• For the participants in the colorectal cancer screening intervention, those under surveillance (i.e., did not have a cancer diagnosis but did have polyps) will also be excluded.

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (3)

Moutain Park Health Center

Phoenix, Arizona, 85012, United States

Location

Hennepin Healthcare

Minneapolis, Minnesota, 55415, United States

Location

Mayo Clinic Minnesota

Rochester, Minnesota, 55905, United States

Location

Related Links

• Mayo Clinic Clinical Trials

Study Officials

• Mark Weiland, MD

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SCREENING
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: June 27, 2023
• First Posted: July 21, 2023
• Study Start: August 1, 2023
• Primary Completion: March 31, 2024
• Study Completion: March 31, 2024
• Last Updated: April 11, 2024

Record last verified: 2024-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (3)